This paper focuses on the infamous case of Hwang Woo Suk, the South-Korean national hero and once celebrated pioneer of stem cell research. After briefly discussing the evolution of his publication and research scandal in Science, I will attempt to outline the main reactions that emerged within scientific and bioethical discourses on the problem of research misconduct in contemporary biosciences. What were the ethical lapses in his research? What kind of research misconduct has been identified? How this kind of misconduct affects scientific integrity? How to avoid it? Focusing on these questions, the paper interprets the Hwang’s case as a case study that might shed light on the worst aspects of highstakes global science. This case presents a group of problems that might endanger scientific integrity and public trust. Regulatory oversight, ethical requirements and institutional safeguards are often viewed by the scientific community as merely decelerating scientific progress and causing delays in the application of treatments. The Hwang’s case represents how unimpeded progress works in contemporary science. Thus, the case might shed light on the often neglected benefits of “the social control of science”.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Dr Stephen Minger.The Fall of a Scientific “Rock Star”. BBC online: (Tuesday, 10 January 2006, 17:53 GMT) http://news.bbc.co.uk/1/hi/sci/tech/4599974.stm.
Following his first international debut in a scientific publication of a biotechnological breakthrough, even commemorative stamps were issued and sold, with an image of stem cells with silhouettes of a man rising from a wheelchair, walking and running. The short existence of the stamps was between the 12th of February, 2005, and 11th of January 2006.
For the more recently appeared discussion about Hwang’s success in parthenogenesis see the postscript at the end of the paper.
Prof. Gerald Schatten of America’s University of Pittsburgh is sought by South Korean prosecution which is investigating Dr. Hwang Woo-Suk’s embryonic cloning research fabrication. The Seoul Times, Wednesday, February 21, 2007 (http://theseoultimes.com/ST/?url=/ST/db/read.php?idx=2983).
For the procedure of prosecution against Hwang, see the postscript at the end of this paper.
Summary of Final Report on Professor Hwang Woo-Suk’s Research, Seoul National University Investigation Committee. http://www.useoul.edu (press release).
Ibid p. 10.
International Committee of Medical Journal Editors: Uniform requirements for Manuscripts Submitted to Biomedical Journals. Updated May 2000 (www.icmje.org).
Who’s the Author? Problems with Biomedical Authorship, and Some Possible Solutions. Report to the Council of Biology Editors (now Council of Science Editors) From the Task Force on Authorship, February 2000 (http://www.councilscienceeditors.org/publications/v23n4p111-119.pdf).
CSE’s White Paper on Promoting Integrity in Scientific Journal Publications. Approved by the CSE Board of Directors on September 13, 2006. (http://www.councilscienceeditors.org/editorial_policies/white_paper.cfm).
See http://www.icmje.org/ at p. 28.
“fabrication, falsification, plagiarism, or other practices that seriously deviate from those that are commonly accepted within the scientific community for proposing, conducting, or reporting research. It does not include honest error or honest differences in interpretations or judgements of data.”
“fabrication, falsification, or plagiarism, in proposing, performing, or reporting research”.
“significant misbehaviour that improperly appropriates the intellectual property or contributions of others, that intentionally impedes the progress of research, or that risks corrupting the scientific record or compromising the integrity of scientific practices. Such behaviors are unethical and unacceptable in proposing, conducting, or reporting research, or in reviewing the proposals or research reports of others.”
Joint Consensus Conference on Misconduct in Biomedical Research. Consensus statement, 28 and 29 October 1999 (http://www.rcpe.ac.uk/esd/consensus/misconduct_99.html).
The European Science Foundation (ESF) and the US Department of Health and Human Services Office of Research Integrity (ORI) have announced plans to hold a World Conference on Research Integrity in Lisbon, Portugal on September 16–19, 2007 (http://www.esf.org/activities/esf-conferences/details/confdetail242/conference-information.html).
In 2002, the ORI reported that 99 institutions had 83 cases of misconduct, with 71 institutions reporting a new allegation. Between 1990 and 2002 the Office of Inspector General at the NSF investigated 800 allegations of misconduct in 600 cases.
Editorial, “Study shows bioethics awareness lacking” Dong-a Ilbo, 25 November 2005, http://english.donga.com/srv/service.php3?biid=2005112564428&path_dir=20051125
Final Report to ESF and ORI, First World Conference on Research Integrity: Fostering Responsible Research. http://www.esf.org/
Hwang, W. S., et al. (2004). Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science, 303(5664), 1669–1674. doi:10.1126/science.1094515. PMID 14963337.
Hwang, W. S., et al. (2005). Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science, 308(5729), 1777–1783. doi:10.1126/science.1112286. PMID 15905366.
Hwang, W. S., et al. (2005). Dogs cloned from adult somatic cells. Nature, 436(7051), 641. doi:10.1038/436641a. PMID 16079832.
Snyder, E. Z., & Loring, J. F. (2006). Beyond fraud—stem-cell research continues. NEJM, 354(4) January 26, p. 321.
Min, J. K. (2005). Stem cell researcher used more eggs than reported. Ohmy News, December 30. (http://.english.ohmynews.com).
Morelle, R. (2007). Moving on from Hwang’s fall. BBC news (http://news.bbc.co.uk/go/pr/fr/-/2/hi/science/nature/6280491.stm) Published: 2007/01/19 18:12:18 GMT.
Check, E. (2005). Where now for stem-cell cloners?—Researchers assess their field after Woo Suk Hwang’s revelations. Nature, 438, 1058–1059.
Zavos, P. (2006). Scientific fabrication at the highest level. January 16 (http://www.zavos.org).
Beardsley, S. (2006). Down in flames—Can stem cell research recover from Woo Suk Hwang? Scientific American, February 20.
Kaplan, K. (2006). Raising science’s bar against fraud. The Los Angeles Times. November 29.
Wade, N. (2006). It may look authentic; Here’s how to tell it isn’t. The New York Times, January 24, 2006.
Cho, M., & McKee, M. (2007). Authorship in biomedical research—realities and expectations. Science’s Next Wave. (http://sciencecareers.sciencemag.org/career_development/previous_issues/articles/1470/authorship_in_biomedical_research_realities_and_expectations/).
Wilson, E. B. (1952). An introduction to scientific research. New York: McGraw Hill.
The GUSTO Investigators. (1993). An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The New England Journal of Medicine, 329(10), 673–682. http://content.nejm.org/cgi/content/short/329/10/673. doi:10.1056/NEJM199309023291001.
Horton, R., & Smith, R. (1996). Time to redefine authorship. BMJ (Clinical Research Ed), 312, 723.
Rennie, D., Flanagin, A., & Yank, V. (2000). The contributions of authors. JAMA, 284(1), 89–91. July 5.
Rennie, D., Yank, V., & Emanuel, L. (1997). When authorship fails. A proposal to make contributors accountable. Journal of the American Medical Association, 278, 579–585. doi:10.1001/jama.278.7.579.
Kassirer, J. P. (1995). Authorship criteria. Science, 268, 785–786.
Cho, M., & McKee, M. (2002). Authorship in biomedical research—realities and expectations. Science’s Next Wave (online) http://nextwave.sciencemag.org/cgi/content/full/2002/01/27/6
Gøtzsche, P. C., et al. (2007). Ghost authorship in industry-initiated randomized trials. PLoS Medicine, 4, e19. doi:10.1371/journal.pmed.0040019.
Gottweis, H., & Triendl, R. (2006). South Korean policy failure and the Hwang debacle. Nature Biotechnology, 2, 141–143.
Cho, M. K., Mcgee, M., & Magnus, D. (2006). Lessons of the stem cell scandal. Science, 3, 614–615. doi:10.1126/science.1124948.
Kim, T.-G. (2007). Science journals shuns korean papers. Korea Times, February 20, 2007. (http://times.hankooki.com/).
Smith, R. (2006). Research misconduct: The poisoning of the well. Journal of the Royal Society of Medicine, 99, 232–237. doi:10.1258/jrsm.99.5.232.
Dresser, R. (2001). Defining research misconduct: Will we know it when we see it? The Hastings Center Report (May–June), 32.
Public Health Service. (1989). Responsibilities of awardee and applicant institutions for dealing with and reporting possible misconduct in science: Final rule. Federal Register, 54, 32449.
NSF. (1991). Misconduct in science and engineering: Final rule. Federal Register, 56, 22287.
Panel on Scientific Responsibility and Conduct of Research. (1992). Responsible science: Ensuring the integrity of the research process. Washington, D.C.: National Academy Press, p. 5.
Commission on Research Integrity. (1996). Integrity and misconduct in research. Washington DC: US Government Printing Office.
Office of Science Technology and Policy. (2000). Federal policy on research misconduct. Federal Register, 65, 76262.
Nylenna, M., Andersen, D., Dahlquist, G., National Committees on Scientific Dishonesty in the Nordic Countries., et al. (1999). Handling of scientific dishonesty in the Nordic countries. Lancet, 354, 57–61. doi:10.1016/S0140-6736(98)07133-5.
Smith, R. (2006). Research misconduct: The poisoning of the well. Journal of the Royal Society of Medicine, 99, 232–237, p. 233.
Smith, R. (2006). Research misconduct: The poisoning of the well. Journal of the Royal Society of Medicine, 99, 232–237, p. 234.
Martinson, B. C., Anderson, M. S., & De Vries, R. (2005). Scientists behaving badly. Nature, 435, 737–738.
De Vries, R., Anderson, M. S., & Martinson, B. C. (2006). Normal misbehavior: Scientists talk about the ethics of research. Journal of Empirical Research on Human Research Ethics, 1(1), 43–50.
Anderson, M. S. (2007). Collective openness and other recommendations for the promotion of research integrity. Science and Engineering Ethics, 13, 387–394. doi:10.1007/s11948-007-9047-0.
Hafferty, F. W., & Franks, R. (1994). The hidden curriculum, ethics teaching and the structure of medical education. Academic Medicine, 69, 861–871. doi:10.1097/00001888-199411000-00001.
I would like to thank Prof. Judit Sándor for her professional support and advice in presenting an early draft of this paper. I would also like to thank two anonymous reviewers for their valuable and in depth comments for improving the original draft.
Written and revised version of the lecture “Cloning, Stem-Cell Research and the Hwang Woo Suk Case” presented in the „Perfect Copy?—Cloning and Stem-Cell Research” Workshop organized by CELAB, Budapest, CEU at 2nd of March 2007.
About this article
Cite this article
Kakuk, P. The Legacy of the Hwang Case: Research Misconduct in Biosciences. Sci Eng Ethics 15, 545 (2009). https://doi.org/10.1007/s11948-009-9121-x
- Hwang Woo Suk
- Stem-cell research
- Research misconduct
- Scientific integrity